Compass Carter Osborne are delighted to announce the launch of our quarterly life sciences newsletter. Led by Principal Matt Dixon and Research Associate Ray Rodriguez, both of them aim to share the latest industry news ranging from fundraising and deals, to research and clinical trial news, as well as notable executive movements.
Overview of the first edition
In this first edition, the newsletter will outline the following:
- A selection of the most notable acquisitions, investments, partnerships and IPO news from Q1 of 2024
- Clinical trial, research and drug approvals – A selection of the most notable clinical trials, R&D and drug approval news from Q1 of 2024
- Executive Moves – A selection of people moves & insights from Q1 2024
To read the newsletter, download the full version here:
Find further information about Compass Carter Osborne news and events.
